Koyfin Home > Directory > Health Care > Adma Biologics > Cash from Financing Activities

Adma Biologics Cash from Financing Activities Chart (ADMA)

Adma Biologics annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Adma Biologics Cash from Financing Activities for the quarter ending September 09, 2020 was $11m a 100.07% increase of 11m year over year
  • Adma Biologics Cash from Financing Activities for the last 12 months ending September 09, 2020 was $112m a 28.46% increase of 32m year over year
  • Adma Biologics Annual Cash from Financing Activities for 2019 was $80m a 46.35% increase of 37m from 2018
  • Adma Biologics Annual Cash from Financing Activities for 2018 was $43m a -41.54% decrease of -18m from 2017
  • Adma Biologics Annual Cash from Financing Activities for 2017 was $61m a 72.28% increase of 44m from 2016
Other Cash Flow Metrics:
  • Adma Biologics Cash Flow from Operations for the quarter ending December 12, 2018 was $-19m a 12.55% decrease of -2m year over year
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Cash from Financing Activities Data

09/2020$11m
06/2020$0m
03/2020$101m
12/2019$0m
09/2019$0m
06/2019$76m
03/2019$4m
12/2018$0m
09/2018$0m
06/2018$43m

Annual ADMA Cash from Financing Activities Data

2019$80m
2018$43m
2017$61m
2016$17m
2015$10m
2014$10m
2013$28m
2012$19m
2011$1m
2010$2m